Unternehmen Stealth BioTherapeutics Corp
Aktien
A2PEJ7
US85789A1051
MITO
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 38
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 59 | 01.01.15 | |
Martin Redmon
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
James R. Carr
CTO | Chief Tech/Sci/R&D Officer | 61 | 17.03.14 |
Janhavi Mohite
IRC | Investor Relations Contact | - | - |
Anthony Walsh
PRN | Corporate Officer/Principal | - | 01.01.22 |
Mike Malynn
HRO | Human Resources Officer | - | - |
Brian Hotchkiss
PRN | Corporate Officer/Principal | - | - |
Brian Blakey
PRN | Corporate Officer/Principal | 61 | 01.02.14 |
Henry H. Hess
LAW | General Counsel | 51 | 01.09.11 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 78 | 04.12.20 | |
Louis Lange
BRD | Director/Board Member | 72 | 24.07.19 |
Kevin McLaughlin
BRD | Director/Board Member | 67 | 14.03.17 |
Edward Owens
BRD | Director/Board Member | 77 | 24.05.17 |
Francis Chen
BRD | Director/Board Member | 75 | 20.04.06 |
Lok Chung Chan
CHM | Chairman | 73 | 22.10.07 |
Chief Executive Officer | 59 | 01.01.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 717 261 322 | 28 068 000 ( 3,913 %) | 0 | 3,913 % |
Unternehmenskontakt
Stealth BioTherapeutics Corp.
140 Kendrick Street Buidling C-West
024494, Needham
+
http://www.stealthbt.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25,69 % | 47,9 Mrd. | |
+46,90 % | 41,42 Mrd. | |
-3,46 % | 40,7 Mrd. | |
-6,20 % | 28,92 Mrd. | |
+9,17 % | 25,55 Mrd. | |
-20,42 % | 19,27 Mrd. | |
+0,17 % | 12,15 Mrd. | |
+28,07 % | 12,14 Mrd. | |
-1,24 % | 11,99 Mrd. |